Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Higher vs. Lower Doses of Dexamethasone in COVID-19
NCT04509973Phase 3Completed
- Sponsor
- Scandinavian Critical Care Trials Group
- Start
- Aug 2020
- Primary completion
- Jun 2021
- Modality
- Orthosteric Ligands
- Countries
- 4
01
Overview
Phase 3, randomised, double-blind trial of dexamethasone in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Scandinavian Critical Care Trials Group. Primary endpoint: Days alive without life support at day 28. Started Aug 2020; status: completed.
02
Drugs
dexamethasone
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04509973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04509973.